Moderna | MRNA - Cash And Equivalent


Moderna reported $1.72B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Acadia Pharmaceuticals USD 956.47M 105.02M Jun/2026
Agios Pharmaceuticals USD 99.65M 13.95M Jun/2026
Alnylam Pharmaceuticals USD 1.71B 2.46M Jun/2026
Amgen USD 13.99B 1.95B Jun/2026
Arrowhead Research USD 19.68M 127.85M Jun/2026
Biogen USD 1.28B 2.1B Jun/2026
BioMarin Pharmaceutical USD 874M 1.35B Jun/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 110.55M 517.12M Jun/2026
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Gilead Sciences USD 7.63B 64M Mar/2026
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Incyte USD 3.98B 33.45M Jun/2026
Ionis Pharmaceuticals USD 350.06M 1.57B Jun/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 1.72B 185M Jun/2026
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
Puma Biotechnology USD 53.52M 1.14M Sep/2025
Qiagen NV USD 646.29M 192.72M Mar/2026
Regeneron Pharmaceuticals USD 2.46B 506.8M Jun/2026
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sarepta Therapeutics USD 571.15M 106.7M Jun/2026
Sartorius EUR 291M 282.8M Jun/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Ultragenyx Pharmaceutical USD 125M 50M Jun/2026
United Therapeutics USD 1.8B 523.5M Jun/2026
Vertex Pharmaceuticals USD 7.85B 605.7M Jun/2026
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026